Prof. Wilson holds the Chair in Drug Metabolism and Molecular Toxicology.
Ian Wilson trained as a biochemist at the University of Manchester Institute of Science and Technology, going on to a PhD at Keele University on insect moulting hormones. After this he worked in the Pharmaceutical industry, most recently as a Senior Principal Scientist in the Dept of Drug Metabolism and Pharmacokinetics at the AstraZeneca Research site at Alderley Park in Cheshire (UK), joining Imperial College in 2012. He is the author, or co-author, of some 480 papers or reviews, and has received a number of awards in separation and analytical science from the Royal Society of Chemistry, including the Gold Medal of the Analytical Division (2005) and most recently the Knox Medal of the RSC Separation Science Group (2012). He received the Jubilee Medal of the Chromatographic Society in 1994 and gave the inaugural Desty Memorial lecture for Innovation in Separation Science in1996. His research is directed towards the development of hyphenated techniques in chromatography and their application to problems in drug metabolism, toxicology and metabonomics
et al., 2021, High-Throughput UHPLC/MS/MS-Based Metabolic Profiling Using a Vacuum Jacketed Column, Analytical Chemistry, Vol:93, ISSN:0003-2700, Pages:10644-10652
et al., 2021, Proteomic consequences of the deletion of cytochrome P450 (CYP450) reductase in mice, Journal of Chromatography B-analytical Technologies in the Biomedical and Life Sciences, Vol:1179, ISSN:1570-0232
et al., 2021, Dysregulation of the Lysophosphatidylcholine/Autotaxin/Lysophosphatidic Acid Axis in Acute-on-Chronic Liver Failure Is Associated With Mortality and Systemic Inflammation by Lysophosphatidic Acid Dependent Monocyte Activation, Hepatology, Vol:74, ISSN:0270-9139, Pages:907-925
et al., 2021, Improving LC/MS/MS-based bioanalytical method performance and sensitivity via a hybrid surface barrier to mitigate analyte-Metal surface interactions, Journal of Chromatography B-analytical Technologies in the Biomedical and Life Sciences, Vol:1179, ISSN:1570-0232
et al., 2021, The pharmacometabodynamics of gefitinib after intravenous administration to mice: a preliminary UPLC–IM–MS study, Metabolites, Vol:11, ISSN:2218-1989, Pages:1-16